The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
News |
Modernising UK homecare will boost neighbourhood health services and save money, says ABPI
News |
Laura McMullin of Daiichi Sankyo named as new ABPI Vice-President
News |
Publication of A Common Understanding 2025
Blog |
Disclosure UK 2024: new record for transparency, with nine in ten healthcare professionals named in database
Best practice guidance: Supporting patient organisations to report industry funding
Transparency is essential when pharmaceutical companies work with patient organisations. This updated guidance is aimed at supporting that transparency.
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.
Events
ABPI Annual Conference 2026
ABPI’s flagship annual conference will be taking place in Central London on 23 April 2026.
Accelerated review of VPAG concludes without agreement
The ABPI can confirm that industry and government have been unable to reach an agreement on changes to a controversial medicines payment scheme which is undermining UK patient access to innovative medicines and the competitiveness of the UK life sciences industry.
Modernising UK homecare will boost neighbourhood health services and save money, says ABPI
The UK’s homecare service potentially saves the NHS £1.67 billion a year, and has the potential to save significantly more through shifting care from hospitals and into patients’ homes.
Laura McMullin of Daiichi Sankyo named as new ABPI Vice-President
The ABPI has appointed Laura McMullin as Vice-President of the ABPI.
Key facts and figures for the pharmaceutical industry in the UK
£46.7bn
Turnover [6]
£9bn
investment in UK R&D (more than UKRI’s entire annual budget) [3]
£17.6bn
direct Gross Value Added (GVA) [1]